article thumbnail

Lilly announces call for Leonard Award nominations as part of global initiative celebrating 100 years of insulin

The Pharma Data

” Five winners – one from each category – will be selected, and Lilly will give $20,000 in recognition of each winner ($100,000 total) to Life for a Child, a non-profit organization that provides access to care, education, and lifesaving medicines and supplies to children and young people with type 1 diabetes in less-resourced countries.

Insulin 52
article thumbnail

Survey reveals healthcare professionals believe greater collaboration is needed to improve patient outcomes in diabetes care

The Pharma Data

Chairman, Department of Medicine, University of Mississippi. Chairman, Department of Medicine, University of Mississippi. The findings are from a survey of 1,000 U.S. healthcare professionals (i.e., Nicholas, M.D., Rachel Pessah-Pollack, M.D., FACE and Jonathan D. The survey included 1,000 U.S.

Nurses 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pfizer Receives Positive CHMP Opinion for Conversion of PAXLOVID™ Conditional Marketing Authorization to Full Marketing Authorization in the European Union

Pfizer

telehealth, in-person visit) with a physician, advanced practice registered nurse, or physician assistant licensed or authorized under state law to prescribe drugs, if any of the following apply: Sufficient information is not available to assess renal and hepatic function.

article thumbnail

Statement from Pfizer Chairman and CEO Albert Bourla on Testing Positive for COVID-19

Pfizer

PAXLOVID may only be prescribed for an individual patient by physicians, advanced practice registered nurses, and physician assistants that are licensed or authorized under state law to prescribe drugs in the therapeutic class to which PAXLOVID belongs (i.e., Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.1

Drugs 99
article thumbnail

FIRST-LINE IBRANCE® (PALBOCICLIB) COMBINATION THERAPY IN HR+, HER2- METASTATIC BREAST CANCER

The Pharma Data

lead researcher and Professor in Breast Cancer Excellence in the Perelman School of Medicine at the University of Pennsylvania. Advise women not to breastfeed during IBRANCE treatment and for 3 weeks after the last dose because of the potential for serious adverse reactions in nursing infants. The most common adverse reactions (?10%)

HR 52
article thumbnail

Pfizer to Provide U.S. Government with an Additional 3.7 Million Treatment Courses of PAXLOVID™ to Help Combat COVID-19

Pfizer

PAXLOVID may only be prescribed for an individual patient by physicians, advanced practice registered nurses, and physician assistants that are licensed or authorized under state law to prescribe drugs. A transient decrease in body weight was observed in the nursing offspring of rats administered nirmatrelvir. Investor Relations. +1

Drugs 110
article thumbnail

Pfizer Responds to Research Claims

Pfizer

A transient decrease in body weight was observed in the nursing offspring of rats administered nirmatrelvir. Contraception: Use of ritonavir may reduce the efficacy of combined hormonal contraceptives. IMPORTANT SAFETY INFORMATION Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5),

Research 112